Streetbeat News

Products Services

SGPYY

Sage Therapeutics has decided to terminate its trial for the therapy dalzanemdor in treating Huntington's disease after it failed to meet its goals. This marks the third failure for the therapy, which also did not succeed in trials for Alzheimer's disease.

Portfolio Pulse from

November 20, 2024 | 1:00 pm

MIRA

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) has announced the selection of The Centre for Human Drug Research in the Netherlands for its Phase I/IIa clinical trial of Ketamir-2, a novel oral ketamine analog. The trial will begin recruitment in Q1 2025, with initial results expected in the second half of 2025.

Portfolio Pulse from

November 20, 2024 | 1:00 pm

DCTH

Delcath Systems is expanding its platform with two Phase 2 trials, funded by $25 million from Tranche B Warrants. Q3 US sales reached $10 million, and the HEPZATO KIT hospital rollout is progressing. Delcath aims to have 15 centers by year-end and 30 by 2025.

Portfolio Pulse from

November 20, 2024 | 1:00 pm

AXREF

Amarc Resources Ltd. has completed its 2024 drilling and survey programs at its JOY, DUKE, and IKE Copper-Gold Districts in British Columbia.

Portfolio Pulse from

November 20, 2024 | 1:00 pm

UHAL

U-Haul has opened a new self-storage facility in Biloxi, Mississippi, marking its first owned and operated store in the city and 14th in the state. The facility offers 344 indoor climate-controlled units.

Portfolio Pulse from

November 20, 2024 | 1:00 pm

DAL

Delta Air Lines Inc (NYSE:DAL) anticipates increased demand for luxury travel, particularly among millennials, which is expected to boost operating profit margins in the future.

Portfolio Pulse from

November 20, 2024 | 1:00 pm

ETOLF

Enterprise Group, Inc. has announced a successful flare gas application for a new client, highlighting its focus on technologies that reduce emissions in the energy sector.

Portfolio Pulse from

November 20, 2024 | 1:00 pm

NVDA

Nvidia's earnings are expected to influence stocks related to AI growth. AI chip suppliers are benefiting from increased spending by 'hyperscalers,' which use AI technology to enhance sales and profits.

Portfolio Pulse from

November 20, 2024 | 12:45 pm

MU

Micron Technology (MU) has seen a 15% drop from recent highs despite strong earnings and a positive Q1 2025 forecast. Concerns about memory demand and oversupply are affecting the stock, but high-margin products are expected to drive growth.

Portfolio Pulse from

November 20, 2024 | 12:45 pm